Crossmark

Current State of Biosimilars in Mexico: The Position of the Mexican College of Rheumatology, 2016

Crossref DOI link: https://doi.org/10.1016/j.reumae.2017.07.003

Published Print: 2018-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Xibille, Daniel

Carrillo, Sandra

Huerta-Sil, Gabriela

Hernández, Ramiro

Limón, Leonardo

Olvera-Soto, Guadalupe

Jara-Quezada, Luis Javier

Esquivel, Abdieel

Pérez-Rodríguez, Marcela
License Information

Text and Data Mining valid from 2018-05-01
More Information

This article is maintained by: Elsevier

Article Title: Current State of Biosimilars in Mexico: The Position of the Mexican College of Rheumatology, 2016

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2017.07.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2017.07.002

Content Type: article

Copyright: © 2017 Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.